Hospitals struggling to attract and retain enough registered nurses at the bedside are implementing alternative strategies to ...

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...

Ultra-processed foods (UPFs) are a leading cause of the "chronic disease pandemic" linked to diet, with food firms putting ...

A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 ...

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

A new study by Phoenix's Barrow Neurological Institute and the University of Calgary has found which injectable treatments showed the most benefit for migraine patients and should be routinely offered ...

For years, the search for a stem cell donor has felt like a quest for a rare key—one that fits a lock with eight intricate tumblers, each representing a genetic marker. For many patients with blood ...

Make way for digital health. Smart watches and health apps aren't just for fitness enthusiasts and people with access to advanced care—the World Health Organization (WHO) is looking to these and other ...

Finland was the first country to offer the zoonotic avian influenza A(H5N8) vaccine manufactured by Seqirus to at-risk ...